Laboratory of Biochemistry, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0818, Japan.
Laboratory of Animal Experiment, Institute for Genetic Medicine, Hokkaido University, Sapporo, 060-0815, Japan.
Mol Metab. 2021 Dec;54:101366. doi: 10.1016/j.molmet.2021.101366. Epub 2021 Oct 30.
The regulation of food intake is a major research area in the study of obesity, which plays a key role in the development of metabolic syndrome. Gene targeting studies have clarified the roles of hypothalamic neurons in feeding behavior, but the deletion of a gene has a long-term effect on neurophysiology. Our understanding of short-term changes such as appetite under physiological conditions is therefore still limited.
Targeted recombination in active populations (TRAP) is a newly developed method for labeling active neurons by using tamoxifen-inducible Cre recombination controlled by the promoter of activity-regulated cytoskeleton-associated protein (Arc/Arg3.1), a member of immediate early genes. Transgenic mice for TRAP were fasted overnight, re-fed with normal diet, and injected with 4-hydroxytamoxifen 1 h after the refeeding to label the active neurons. The role of labeled neurons was examined by expressing excitatory or inhibitory designer receptors exclusively activated by designer drugs (DREADDs). The labeled neurons were extracted and RNA sequencing was performed to identify genes that are specifically expressed in these neurons.
Fasting-refeeding activated and labeled neurons in the compact part of the dorsomedial hypothalamus (DMH) that project to the paraventricular hypothalamic nucleus. Chemogenetic activation of the labeled DMH neurons decreased food intake and developed place preference, an indicator of positive valence. Chemogenetic activation or inhibition of these neurons had no influence on the whole-body glucose metabolism. The labeled DMH neurons expressed prodynorphin (pdyn), gastrin-releasing peptide (GRP), cholecystokinin (CCK), and thyrotropin-releasing hormone receptor (Trhr) genes.
We identified a novel cell type of DMH neurons that can inhibit food intake and promote feeding-induced positive valence. Our study provides insight into the role of DMH and its molecular mechanism in the regulation of appetite and emotion.
摄食调控是肥胖研究的一个主要领域,在代谢综合征的发生发展中起着关键作用。基因靶向研究已经阐明了下丘脑神经元在摄食行为中的作用,但基因缺失对神经生理学的长期影响尚不清楚。因此,我们对生理条件下食欲等短期变化的了解仍然有限。
活性神经元靶向重组(TRAP)是一种新的方法,通过使用他莫昔芬诱导型 Cre 重组酶,由活性调节细胞骨架相关蛋白(Arc/Arg3.1)启动子控制,对活跃神经元进行标记,Arc/Arg3.1 是即时早期基因的成员。TRAP 转基因小鼠隔夜禁食,重新喂食正常饮食,再喂食后 1 小时注射 4-羟基他莫昔芬以标记活跃神经元。通过表达兴奋性或抑制性 Designer 受体(DREADDs),专门激活 Designer 药物,来检测标记神经元的作用。提取标记神经元进行 RNA 测序,以鉴定在这些神经元中特异性表达的基因。
禁食-再喂食激活并标记了投射到室旁核的下丘脑背内侧核(DMH)的致密部的神经元。化学遗传激活标记的 DMH 神经元可减少食物摄入并产生正性效价的位置偏好。化学遗传激活或抑制这些神经元对全身葡萄糖代谢没有影响。标记的 DMH 神经元表达前强啡肽(pdyn)、胃泌素释放肽(GRP)、胆囊收缩素(CCK)和促甲状腺素释放激素受体(Trhr)基因。
我们鉴定了一种新型的 DMH 神经元,它可以抑制摄食并促进摄食诱导的正性效价。我们的研究为 DMH 的作用及其在食欲和情绪调节中的分子机制提供了新的见解。